Tuesday, July 17, 2007 1:31:06 PM
NRMX - Neurochem Inc.
(Neurochem) is a biopharmaceutical company focused on the development and commercialization of therapeutics to address the medical needs. The Company’s pipeline of oral product candidates primarily targets neurological disorders. The business activities of Neurochem has been focused principally to the development of the Company’s core technology platform, amyloid inhibitors, which focuses on chemical compounds that could have the potential to inhibit the formation, deposition and toxicity of amyloid fibrils.
News .. Financial Highlights .. Analyst Estimates .. Option Chain .. IV ..Candlestick Analysis..Short Interest.
.
.
(Neurochem) is a biopharmaceutical company focused on the development and commercialization of therapeutics to address the medical needs. The Company’s pipeline of oral product candidates primarily targets neurological disorders. The business activities of Neurochem has been focused principally to the development of the Company’s core technology platform, amyloid inhibitors, which focuses on chemical compounds that could have the potential to inhibit the formation, deposition and toxicity of amyloid fibrils.
News .. Financial Highlights .. Analyst Estimates .. Option Chain .. IV ..Candlestick Analysis..Short Interest.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
